Bupivacaine Injections vs. IV Medications for Headache Treatment
This study is comparing two ways to treat headaches in the emergency room: an injection of 0.5% Bupivacaine HCl into the neck muscles, or standard intravenous (IV) medications chosen by the doctor. The goal is to see which treatment works better for pain relief. You might be able to join if you are 18 or older, speak English, and have a non-traumatic headache with a pain level of 5 or higher out of 10. You cannot join if you have certain conditions like an allergy to bupivacaine, a bleeding disorder, or are pregnant. The study will measure your pain level 24 hours after treatment to see how well each method worked. The current status of this study is unclear, and it plans to enroll 100 participants.
- Study design
- This interventional study plans to enroll 100 participants to compare two headache treatments. It is not specified if it is randomized or blinded.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants' pain levels will be measured 24 hours after treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
0.5% Bupivacaine Lower Cervical Intramuscular Injection vs IV Medications for Headache Treatment
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Robyn Hoelle, MD · PRINCIPAL_INVESTIGATOR · HCA north florida hospital emergency department
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Visual analog scale pain score 0-1024 hours
Pain score at 30 minutes and 24 hours after treatment. 0 being no pain and 10 being the worse pain possible.